Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.
Pharmaceutical Executive Daily: Novartis Acquires Excellergy Inc.

In today's Pharmaceutical Executive Daily, Novartis agrees to acquire Excellergy for up to $2 billion to advance a next-generation anti-IgE therapy w…

7 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Trump Administration Misses Deadline to Nominate Permanent CDC Director
Pharmaceutical Executive Daily: Trump Administration Misses Deadline to Nominate Permanent CDC Director

In today's Pharmaceutical Executive Daily, the Trump administration misses a statutory deadline to nominate a permanent CDC director, leaving the age…

7 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio

In today's Pharmaceutical Executive Daily, the FDA issues a warning letter to ImmunityBio over misleading promotional claims about its bladder cancer…

7 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake
Pharmaceutical Executive Daily: Bayer Shares Drop After Inclusive Capital Offloads Remaining Stake

In today's Pharmaceutical Executive Daily, Bayer shares briefly dip after activist investor Inclusive Capital offloads its remaining stake at a loss,…

7 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer

In today's Pharmaceutical Executive Daily, Pfizer warns shareholders to reject an unsolicited mini-tender offer from Tutanota LLC seeking to purchase…

7 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
Pharmaceutical Executive Daily: FDA Approves Wegovy HD

In today's Pharmaceutical Executive Daily, Novartis agrees to acquire a pan-mutant-selective inhibitor from Synnovation Therapeutics in a deal worth …

7 months, 4 weeks ago

Short Long
View Episode
The Ron Lanton Report: When Policy Becomes a Capital Event
The Ron Lanton Report: When Policy Becomes a Capital Event

The episode explores how regulatory signals across drug approvals, trade policy, AI governance, and drug pricing shape business strategy and investor…

7 months, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing
Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing

In today's Pharmaceutical Executive Daily, a new analysis finds that TrumpRx is listing prices for roughly a third of its featured drugs higher than …

7 months, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Federal Judge Halts Vaccine Advisory Council Appointments
Pharmaceutical Executive Daily: Federal Judge Halts Vaccine Advisory Council Appointments

In today's Pharmaceutical Executive Daily, a federal judge blocks RFK Jr.'s reconstituted vaccine advisory committee and halts its policy changes, a …

8 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains
Pharmaceutical Executive Daily: Conflict in Middle East Disrupts Pharma Supply Chains

In today's Pharmaceutical Executive Daily, ongoing conflict in the Middle East is straining pharmaceutical supply routes to the Gulf region, Sentynl …

8 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us